Recent Study Highlights the Dangers of Unapproved Stem Cell Therapy
ColiN00B / Pixabay

Recent Study Highlights the Dangers of Unapproved Stem Cell Therapy

According to a story from Medical Xpress, a team of researchers from the American Association of Ophthalmology recently released a study that highlights the dangers of unapproved stem cell therapy.…

Continue Reading Recent Study Highlights the Dangers of Unapproved Stem Cell Therapy
Experimental Treatment for NF-1 Gets Orphan Drug Designation
frolicsomepl / Pixabay

Experimental Treatment for NF-1 Gets Orphan Drug Designation

According to a story from BioPortfolio, the biopharmaceutical company SpringWorks Therapeutics recently announced that the US Food and Drug Administration (FDA) has given the company's experimental product PD-0325901 Orphan Drug…

Continue Reading Experimental Treatment for NF-1 Gets Orphan Drug Designation
Rare Blood Cancer Trial Data to be Presented in Upcoming Conference
allinonemovie / Pixabay

Rare Blood Cancer Trial Data to be Presented in Upcoming Conference

According to a story from investors.amgen.com, the drug developer Amgen recently announced its intent to present all new clinical trial data which will feature its latest work in testing a…

Continue Reading Rare Blood Cancer Trial Data to be Presented in Upcoming Conference
Close Menu